ESR1 and breast cancer: With immunohistochemistry (IHC), BC is classified by the presence/absence of Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2/neu) (Tang et al., 2016).